Stay Updated with the Latest Guardian Metal Resources PLC Sponsored ADR GMTL News in Real Time
Find GMTL news now at Meyka AI. Stay informed with the latest Guardian Metal Resources PLC Sponsored ADR stocks updates, including price news, market analysis, and expert insights.
Craneware (LON:CRW) Shares Plunge 23% to Lowest Level Since 2016 After Cutting FY Revenue Outlook
Craneware plc shares fell as much as 23% today, touching an intraday low of 988 pence. That marks the stock’s lowest level since November 28, 2016. The Edinburgh-based healthcare financial software firm issued an unscheduled trading update warning that full-year results would miss market expectations. Craneware now guides FY26 revenue to $205 million to $208…
Alibaba to Ban Claude Code in Workplace Over Alleged Backdoor Security Risks, Report Says
Alibaba will ban employees from using Anthropic’s Claude Code starting July 10, 2026. Reuters reported the move Thursday, citing a source familiar with the decision. The ban stems from alleged security risks involving embedded backdoors in the coding tool. Chinese financial outlet Yicai first reported the story earlier this week. Alibaba shares fell 0.7% on…
Zuckerberg Says Meta’s AI Agent Development Is Progressing Slower Than Expected Despite Massive Spending
On July 2, 2026, Meta CEO Mark Zuckerberg said the company’s AI agent development is moving more slowly than expected, despite spending billions of dollars on infrastructure, hiring, and research. The comments caught many by surprise because Meta has been investing heavily in artificial intelligence to keep pace with its biggest competitors. The update raises…
SK Hynix Inc (KRX: 000660) Climbs +11.32% to 2,434,500 KRW After BitMart Announces Stock Listing & Incentive Program
On July 3, 2026, SK Hynix Inc. (KRX: 000660) climbed 11.32% to 2,434,500 KRW, catching the attention of investors focused on AI and semiconductor stocks. Buying picked up after BitMart announced a stock listing and incentive program, giving the shares an extra boost during the session. Even so, much of the market’s attention remains on…
NZE Stocks Rally: Santana Minerals Climbs 4%+ While Ventia Services Drops Over 2% as Sector Performance Diverges
On July 3, 2026, New Zealand equities moved in different directions as investors shifted between sectors. Santana Minerals gained more than 4%, helped by renewed buying in mining stocks, while Ventia Services fell over 2% as infrastructure-related shares came under pressure. The difference in performance reflected where investors were putting their money during the latest…
MCX Gold & Silver Today: Gold Jumps 1.40%, Silver Surges 1.80% as Fed Rate Cut Hopes Boost Bullion
MCX Gold and MCX Silver rallied sharply on July 3, 2026. Gold futures climbed 1.40% to trade near ₹1,41,900 per 10 grams. Silver futures surged 1.80%, touching roughly ₹2,06,500 per kilogram. Weak US jobs data triggered the rally, with June payrolls adding just 57,000 jobs. That figure missed forecasts of 110,000 by a wide margin….
Wipro Ltd Share Price Rises 2.25% to ₹173.95 Despite 17% Drop in ADRs on Nasdaq
Wipro Ltd share price climbed 2.25% to ₹173.95 on the NSE on Thursday, July 2, 2026. This came even as Wipro’s American Depositary Receipts fell 16.89% overnight on the NYSE to $1.870. Domestic buying tracked a broader Nifty IT rebound rather than following the sharp ADR weakness. JPMorgan downgraded Wipro Ltd to Underweight from Neutral,…
Vedanta Iron and Steel Shares Soar 94% Since Listing at ₹20, Hit Upper Circuit at ₹38.78
Vedanta (VEDL) Iron and Steel shares extended their blistering rally today, July 1, 2026. The stock touched an intraday high of ₹38.78 on the NSE, locking in a 10% upper circuit. That marks a 93.9% gain from its ₹20 listing price on June 15. The rally comes days after the stock exited its mandatory Trade-to-Trade…
AlzeCure Shares Soar 71% to Highest Since 2022 on $2.2 Billion Alzheimer’s Drug Licensing Deal
AlzeCure shares surged 71% on June 30, 2026, reaching their highest level since early 2022 after the Swedish biotech company announced an Alzheimer’s drug licensing agreement valued at more than $2.2 billion, excluding royalties. The deal gives global development and commercialization rights to its lead candidate, ACD856, and marks a major milestone for the company….